By Kenneth E. Thorpe
The Trump administration is pressing forward with Nafta renegotiations. America's trade representatives tried to resolve their disagreements with their Mexican and Canadian counterparts in informal meetings throughout December. A sixth round of talks will take place in Montreal next week.
The administration hopes to safeguard the rights of American firms that export tangible goods, like agricultural produce and automobiles. That's a worthy goal. But negotiators should also protect intangible exports and foster an economic environment that promotes research and development — namely, by fighting abusive price controls and protecting intellectual property.
These protections spur the development of new medicines, and medical breakthroughs are desperately needed to stem the rising tide of chronic disease.